Biosimilar antibodies are research-use-only (RUO) recombinant antibodies, which incorporate the same variable region sequence as the therapeutic antibodies. Although they are not produced by the same method as for therapeutic purposes, these biosimilar antibodies are commonly used to study the effects of original therapeutic antibodies without the necessity to source costly pharmaceutical-grade reagents.
Leadgene offers about two hundred RUO-grade biosimilar antibodies.
The ones offered are:
Human surrogate with sequence defined
Sterilized and low endotoxin
Secured supply with consistent lot-to-lot performance
GMP-grade available (on demand)
Download the list of Leadgene's biosimilar antibodies or isotype control.
Contact us for details by emailing [email protected]
